|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's range||71.04 - 72.63|
|52-week range||60.14 - 84.00|
|PE ratio (TTM)||11.07|
|Earnings date||8 Aug 2018|
|Forward dividend & yield||2.00 (2.85%)|
|1y target est||86.80|
CVS Health CEO Larry Merlo tells CNBC's Bertha Coombs he expects to close the $69 billion deal to buy Aetna later this year.
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want a simplistic look at the returnRead More...
The stock performance of Walgreens Boots (WBA) currently does not offer much conviction. Over the past year, shares show a decline of 17.9%.
Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? The company is rated a 2.3 on a scale where one is a “strong buy” and five is a “strong sell.” It was rated a 2.0 at the end of June 2017. In comparison, CVS Health has a slightly better rating of 2.0, while Rite Aid (RAD) has a rating of 3.0.
Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? Walgreens Boots Alliance (WBA) is currently trading at a one-year forward earnings multiple of 11x as of June 20. Walgreens’s close competitor CVS Health (CVS) is also trading at similar valuations.
Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? Walgreens stock has witnessed high levels of volatility over the past year. The pharmacy giant, which is currently trading at $68 as of June 20, has been in the range of $61.56 and $83.89 over the last-12-month period.
Walgreens Boots Alliance’s (WBA) stock gained 5.2% yesterday after the S&P Dow Jones Indexes announced that Walgreens would replace General Electric (GE) in the Dow Jones Industrial Average Index starting June 26. The news reduced Walgreens’s YTD losses from 11% to just about 6%.
Wall Street has projected an 11.3% YoY (year-over-year) jump in Walgreens Boots Alliance’s (WBA) earnings per share to $1.48 for the third quarter of 2018. The pharmacy giant has not missed Wall Street expectations in the last 15 quarters. For full fiscal 2018, the company’s EPS (or earnings per share) are anticipated to see a ~17% YoY improvement to $5.96, which is above the midpoint of the management’s guidance range of $5.85 to $6.05 for the year.
When the CEOs of Amazon.com (AMZN), Berkshire Hathaway (BRK.A), and JPMorgan Chase (JPM) announced on Jan. 30 that they were joining forces to create a not-for-profit health care venture to reduce costs and improve care for their companies’ 1.1 million employees, shares of health care companies tumbled. Jan. 30, 2018 performance: UnitedHealth Group (UNH) -4.4% Anthem (ANTM) -5.3% Aetna (AET) -3.0% Humana (HUM) -3.1% CVS Health (CVS) -4.1% Walgreens Boots (WBA) -5.2% Express Scripts Holding Company (ESRX) -3.2% Cardinal Health (CAH) -1.8% Investors were afraid the new initiative would disrupt the health care industry as we know it, with the announcement explaining that the focus would be on using technology to “provide U.S. employees and their families with simplified, high-quality and transparent health care at a reasonable cost.” That wording, backed by the collective clout of Jeff Bezos, Warren Buffett, and Jamie Dimon, was enough to spook health care investors into dumping their shares.
The S&P 500’s top gainers on June 19 were: Assurant (AIZ) gained 4.6%. CVS Health (CVS) gained 4.5%. Netflix (NFLX) gained 3.73%. Regeneron Pharmaceutical (REGN) gained 3.6%. Cimarex Energy (XEC) gained 3.5%. Assurant
CVS Health Corp. has enlisted the U.S. Postal Service for a new home delivery service, as the drugstore giant strives to stave off Amazon.com Inc. and other rivals. CVS struck a deal with the Postal Service to pick up prescriptions at CVS stores and bring them to customers’ homes in one or two days. CVS is rolling out the nationwide service as it fights falling sales in its roughly 9,800 pharmacies and braces for potential competition from Amazon, which has considered launching a prescription offering and has made a bigger push into medical supplies.
Today, CVS Health, the leading pharmacy benefit managers, is up ~5% after announcing the launch of its drug delivery service from all of its US locations. The company has nearly 10,000 stores across the United States, and it expects to deliver customer orders within a day or two of customers placing orders on the website or app. The company also plans to offer same-day delivery service in some major cities.
The department store chain is also about to start testing mini Sears shops, selling appliances, inside its Kmart locations.
They plan to open two locations inside Walgreens stores this fall in the Kansas City, Missouri, area with primary care services, pharmacies and other services like a Humana representative to answer seniors' Medicare questions.
CVS Health will make prescription deliveries nationwide to accommodate the heightened expectations of convenience from consumers. The nation's second-largest drugstore chain says it also will make home deliveries of other items, like allergy medicines, vitamins or household products. The drugstore chain said Tuesday that it's expanding same-day deliveries, for a higher fee, to Boston, Miami, Philadelphia, San Francisco and Washington, DC.
CVS' move will be a test of whether patients are willing to wait for their medicines in exchange for the convenience of delivery.
Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health
York Capital Management founder Jamie Dinan expects a wave of mergers now that a federal judge has ruled the AT&T-Time Warner deal can move forward.
CVS Health Corporation (NYSE:CVS) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...
While the world focused on the shares of media companies after a federal judge approved AT&T's (T) proposed $85 billion acquisition of Time Warner (TWX), other industries also benefited from the prospects of mega-deals. As Barron's Varada Bhat wrote, the S&P 500's top-performing stocks on Wednesday were either already involved in merger activities, or those that might be. Pharmacy chain CVS Health (CVS) announced plans to acquire Aetna (AET) for $69 billion in December.